Amarin Corp. ADR buy stratec
Summary
This prediction ended on 11.01.20 with a price of €17.00. The price of Amarin Corp. ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.46%. stratec has 50% into this predictionAmarin Corporation plc (Symbol AMRN) is a biopharmaceutical company that is focused on the development and commercialization of therapeutics to improve cardiovascular health. The company's main product, Vascepa, is a prescription medication that has been approved by the US FDA for use as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia. Vascepa has also shown to reduce the risk of cardiovascular events such as heart attack and stroke in patients with elevated cardiovascular risk. As a listed company, Amarin is publicly traded on the NASDAQ stock exchange and has a market capitalization of approximately $5 billion as of August 2021.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Amarin Corp. ADR | 0.000% | 0.000% | -42.564% | -88.618% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by stratec for this prediction
In the thread Amarin Corp. ADR diskutieren
Stopped prediction by stratec for Amarin Corp. ADR
Amarin Corp. ADR
08.03.20
21.03.20
21.03.20
Amarin Corp. ADR
23.02.20
08.03.20
08.03.20
Amarin Corp. ADR
28.01.20
08.02.20
08.02.20